CAPRICOR THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
CAPRICOR THERAPEUTICS, INC. (CAPR) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $110.64 thousand as of 2019-12-31, per its 10-K filed 2020-03-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-03-27
- 2019-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $110.64K.
- 2019-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $125.02K.
- 2019-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $171.01K.
- 2019-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $296.02K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2019-12-31 | $110.64K 10-K · filed 2020-03-27 |
| 2019-09-30 | $125.02K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $171.01K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $296.02K 10-Q · filed 2019-05-14 |
| 2016-09-30 | $127.03K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $254.07K 10-Q · filed 2016-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |